PSYGF (Psyence Group) Debt-to-Equity : 0.00 (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Psyence Group Debt-to-Equity?

Psyence Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.00 Mil. Psyence Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.00 Mil. Psyence Group's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $-16.77 Mil. Psyence Group's debt to equity for the quarter that ended in Dec. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Psyence Group's Debt-to-Equity or its related term are showing as below:

PSYGF' s Debt-to-Equity Range Over the Past 10 Years
Min: -4.31 Med: 0.06 Max: 1.86
Current: -0.07

During the past 5 years, the highest Debt-to-Equity Ratio of Psyence Group was 1.86. The lowest was -4.31. And the median was 0.06.

PSYGF's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.28 vs PSYGF: -0.07

Psyence Group Debt-to-Equity Historical Data

The historical data trend for Psyence Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group Debt-to-Equity Chart

Psyence Group Annual Data

Trend

Dec19

Dec20

Mar22

Mar23

Mar24

Debt-to-Equity

0.49

0.04

-0.52

Psyence Group Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial												0.08	-0.52	-0.39	-0.08	-

Competitive Comparison of Psyence Group's Debt-to-Equity

For the Drug Manufacturers - General subindustry, Psyence Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Group's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Psyence Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Psyence Group's Debt-to-Equity falls into.

Psyence Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Psyence Group's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.142	+	0.024)	/	-17.643
	=	-0.52

Psyence Group's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-16.768
	=	0.00

Psyence Group (OTCPK:PSYGF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Psyence Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Psyence Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (OTCPK:PSYGF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

PSYG:Canada

Address

121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.

Psyence Group Headlines

No Headlines